PHAdustry
Creates Industry 4.0 in the era of biomanufacturing
Production Line Introduction
Beijing, China
Synthetic Biology Flexible Intelligent Manufacturing Line
The synthetic biology flexible intelligent manufacturing line is located in the northern area of Beijing Sino-German Industrial Park, which is the headquarters of PhaBuilder. It was established in October 2022.
Based on the R&D capabilities of the PHAmily series, the intelligent manufacturing line has diverse product manufacturing capabilities, specifically designed for the production of various types of PHA products that meet a variety of differentiated downstream demands, as well as customized high-value medical implant materials.
  • Multiple Types of PHA

    The production line capable of mass-producing the most types of PHA in the world

  • Transparent Forward and Reverse Fermentation Tank

    The world's first, joint mechanical development with Tsinghua University

  • Digital Operations

    Digital Operations

Production Line Introduction
Shanghai, China
R&D Center
The Shanghai R&D Center is located in Zhangjiang, Shanghai, and is PhaBuilder's innovative layout in March 2024. Relying on Shanghai's superior R&D resources and industrial resources, PhaBuilder connects with global industrial partners to jointly develop PHA-based product solutions.
  • Global Cooperation

    Shanghai’s openness has attracted many foreign-funded enterprises and R&D centers, which has helped introduce international advanced technologies and management experience and improved R&D levels.

  • Complete Industry Chain

    The international level of upstream and downstream industrial chain provides abundant cooperation opportunities and application scenarios for the material research and development center

  • Talent Gathering

    Shanghai gathers the regional headquarters or R&D centers of top pharmaceutical companies from around the world, as well as several well-known universities, which provides both talent and technology support for the materials R&D center and is conducive to carrying out high-level scientific research activities.

Production Line Introduction
Yichang, China
Weiqi Biotechnology
In July 2022, PhaBuilder established Weiqi Biotechnology in a joint venture with Angel Biotech, a world-leading yeast company.
The project is located in Hubei Synthetic Biology Industrial Park, with a total investment of RMB 1.05 billion and a total construction area of over 80,000 square meters.
  • Annual Production of 30,000 Tons

    The world's largest NGIB system biomanufacturing plant

  • Smart Factory

    Combining Industry 4.0 technologies to build a biomanufacturing large model

  • Non-grain Carbon Source

    Capable of utilizing non-grain carbon sources for production and manufacturing

Production Line Introduction
China · West
Weining Biotechnology
In January 2024, PhaBuilder established Weining Biotechnology in a joint venture with listed company Chuanning Biotechnology.
Weining Biotechnology will focus on the medical field, develop medical-grade PHA raw materials and related applications, achieve new breakthroughs in PHA in the field of biomedical materials, and promote the integration of PHA into the global biomedical innovation system.
  • Medical Grade Production Line

    Chuanning Biotechnology’s experience in biomedicine + PhaBuilder's synthetic biology technology

  • BRI Services

    Serve Asian and European customers through the Belt and Road Initiative

  • Integrate PHAdustry

    Global leading technology + experience in industrialization of biomanufacturing + advantage resources in bulk materials

Global Layout
PhaBuilder Global Layout

Biomanufacturing + Industry 4.0
Learn about and purchase PhaBuilder PHA
The process digital control rate of the synthetic biology production line reaches 80%
The number of fermentation operators is reduced from the usual 4 to 1
Operation and maintenance efficiency is increased by more than 70%
Simultaneously, more than 10,000 sets of fermentation data were captured using biosensors for precision fermentation.
Precision Fermentation Large Model
Modular Replication
Delivering standardized capabilities to the industry
  • Building Big Data

    Biosensors
    10,000+ data modules

  • Building an Industrial AI Large Model

    Modular production
    Scaled replication
    Industry solutions

  • Formulate Precision Production Strategies

    Production strategy optimization
    Precision fermentation

  • Optimizing Supply
  • Reduce Costs
  • Improve Energy Efficiency
  • Sustainability
  • Create a Global Benchmark
Production Line Introduction
Beijing, China
Synthetic Biology Flexible Intelligent Manufacturing Line
The synthetic biology flexible intelligent manufacturing line is located in the northern area of Beijing Sino-German Industrial Park, which is the headquarters of PhaBuilder. It was established in October 2022.
Based on the R&D capabilities of the PHAmily series, the intelligent manufacturing line has diverse product manufacturing capabilities, specifically designed for the production of various types of PHA products that meet a variety of differentiated downstream demands, as well as customized high-value medical implant materials.
  • Multiple Types of PHA

    The production line capable of mass-producing the most types of PHA in the world

  • Transparent Forward and Reverse Fermentation Tank

    The world's first, joint mechanical development with Tsinghua University

  • Digital Operations

    Digital Operations

Production Line Introduction
Shanghai, China
R&D Center
The Shanghai R&D Center is located in Zhangjiang, Shanghai, and is PhaBuilder's innovative layout in March 2024. Relying on Shanghai's superior R&D resources and industrial resources, PhaBuilder connects with global industrial partners to jointly develop PHA-based product solutions.
  • Global Cooperation

    Shanghai’s openness has attracted many foreign-funded enterprises and R&D centers, which has helped introduce international advanced technologies and management experience and improved R&D levels.

  • Complete Industry Chain

    The international level of upstream and downstream industrial chain provides abundant cooperation opportunities and application scenarios for the material research and development center

  • Talent Gathering

    Shanghai gathers the regional headquarters or R&D centers of top pharmaceutical companies from around the world, as well as several well-known universities, which provides both talent and technology support for the materials R&D center and is conducive to carrying out high-level scientific research activities.

Production Line Introduction
Yichang, China
Weiqi Biotechnology
In July 2022, PhaBuilder established Weiqi Biotechnology in a joint venture with Angel Biotech, a world-leading yeast company.
The project is located in Hubei Synthetic Biology Industrial Park, with a total investment of RMB 1.05 billion and a total construction area of over 80,000 square meters.
  • Annual Production of 30,000 Tons

    The world's largest NGIB system biomanufacturing plant

  • Smart Factory

    Combining Industry 4.0 technologies to build a biomanufacturing large model

  • Non-grain Carbon Source

    Capable of utilizing non-grain carbon sources for production and manufacturing

Production Line Introduction
China · West
Weining Biotechnology
In January 2024, PhaBuilder established Weining Biotechnology in a joint venture with listed company Chuanning Biotechnology.
Weining Biotechnology will focus on the medical field, develop medical-grade PHA raw materials and related applications, achieve new breakthroughs in PHA in the field of biomedical materials, and promote the integration of PHA into the global biomedical innovation system.
  • Medical Grade Production Line

    Chuanning Biotechnology’s experience in biomedicine + PhaBuilder's synthetic biology technology

  • BRI Services

    Serve Asian and European customers through the Belt and Road Initiative

  • Integrate PHAdustry

    Global leading technology + experience in industrialization of biomanufacturing + advantage resources in bulk materials